stockmarketproxy
/
PODDNasdaq SEC EDGAR

INSULET CORP

Surgical & Medical Instruments & Apparatus·ACTON, MA·FY end 12/31·CIK 1145197
OverviewFinancialsCompensationGovernanceInsidersFilings

Financials

5-year history · USD
MetricFY 2025FY 2024FY 2023FY 2022FY 2021Trend
Revenue$2.7B$2.1B$1.7B$1.3B$1.1B
Gross Profit$1.9B$1.4B$1.2B$805.6M$752.1M
Operating Income$473.8M$308.9M$220.0M$37.6M$126.0M
Net Income$247.1M$418.3M$206.3M$4.6M$16.8M
Operating CF$569.3M$430.3M$145.7M$119.0M-$68.1M
Capex$191.6M$124.9M$75.6M$122.9M$111.9M
Free Cash Flow$377.7M$305.4M$70.1M-$3.9M-$180.0M
Buybacks$59.6M—————
Dividends——————
Gross Margin71.6%69.8%68.3%61.7%68.4%
Operating Margin17.5%14.9%13.0%2.9%11.5%
Net Margin9.1%20.2%12.2%0.4%1.5%
FCF Margin13.9%14.7%4.1%-0.3%-16.4%
R&D / Revenue11.1%10.6%12.1%13.8%14.6%
Effective Tax27.2%-39.3%3.9%53.1%18.0%
Debt / Equity———5.834.53
Buybacks / FCF15.8%—————

Peer comparison

Surgical & Medical Instruments & Apparatus · 5 peers
CEO Pay Ratio
PODD
213:1
BSX
348:1
SYK
264:1
MMM
316:1
BAX
257:1
BDX
374:1
CEO total comp
PODD
$19M
BSX
$24M
SYK
$21M
MMM
$21M
BAX
$18M
BDX
$17M
Net Margin
PODD
9.1%
BSX
—
SYK
11.8%
MMM
13.0%
BAX
-8.5%
BDX
7.7%